|ID:389 ||Clomipramine||Search Links: General Info : Protocols : Patient Info|
|Description||This test is no longer routinely available. Please contact the Duty Biochemist for further discussion if required Tricyclic antidepressant drug. Please state on form whether pre-dose or date and time of last dose.|
|Indication||Monitoring of toxicity.|
|Additional Info||Side effects: tachycardia, blurred vision, constipation, hesitancy in micturation, cardiac arrthythmias. Metabolised to norclomipramine.
|Interpretation||>1000 ug/l may be associated with serious toxicity. Plasma half-life 20-40 hrs.
|Ref. Range (Male)||See note|
|Ref. Range (Female)|| |
|Ref. Range (Paed)|| |
|Ref. Range Notes||Target range of 150-450 ug/l has been suggested.
|IP Acute TAT||- Contact Laboratory|
|IP Routine TAT||At least 1 week|
|GP Acute TAT||- Contact Laboratory|
|GP Routine TAT||At least 1 week|
|Turnround Comment||Dr Alun Hutchings:HutchingsAD@cardiff.ac.uk|
Originally edited by : . Last edited on 23/11/2018 16:40:27. Published By on 23/11/2017 16:40:27.